Sep 2, 2015
The course will take place at the waterfront offices of Gunderson, Dettmer in downtown Boston and includes all the important steps of deal preparation and execution including commercial assessment, valuation, outreach and negotiations. We hope you can join us. Event...
Aug 24, 2015
The panel is Part III of MassBio’s Forum Series: The New Biopharma BD Landscape—All You Need to Know to Survive & Thrive. Hear Jay Mohr moderate on Tuesday, September 22nd at 8:00 a.m. Click here for the link.
Jul 23, 2015
Questions that Cause Biotech CEOs to Lose Sleep: Should I divert funds to the new and promising program or stay focused? Does my team have the skills to take us to the next level? Is our board the right board for the company we want to be? How can I get the best...
Jul 23, 2015
Article appearing in Life Science Reader, by Jay Mohr, managing director and founding member, Locust Walk Partners. You can’t blame specialty pharma companies for looking over their shoulders lately. For the smaller fish in the specialty pharma pond, a shadow circling...
May 18, 2015
Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing Cortendo Enters Into Agreements to Acquire Aspireo Pharmaceuticals’ Somatoprim (DG3173) and In-License Antisense Therapeutics’ ATL1103...